TST001
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for TST001, covering 2023-07-27 to 2025-12-19. Get the full timeline:
Most recent: Clinical Trial Update: A Trial to Evaluate Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of TST001 in Advanced or Metastatic Solid Tumors [Phase 1, Phase 2]